Joost F. Swart

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

Angelo Ravelli, Alessandro Consolaro, Gerd Horneff et al. · Annals of the Rheumatic Diseases · 2018 · 357 citations · Full text

Medicine, Clinical Sciences, Pediatrics +13

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi et al. · The Lancet Child & Adolescent Health · 2019 · 214 citations · Full text

Medicine, Child Health, Pediatrics +16

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study

Nienke M. ter Haar, E. H. Pieter van Dijkhuizen, Joost F. Swart et al. · Arthritis & Rheumatology · 2019 · 186 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Predictors of health‐related quality of life in children and adolescents with juvenile idiopathic arthritis: Results from a web‐based survey

Lotte Haverman, Martha A. Grootenhuis, J. Merlijn van den Berg et al. · Arthritis Care & Research · 2012 · 153 citations

Medicine, Child Health, Pediatrics +14

Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

M.H. Otten, Femke H. M. Prince, Wineke Armbrust et al. · JAMA · 2011 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13